Interventions for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Interventions for neovascular age-related macular degeneration

Published:2016-10-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Evans Jennifer R¹,Virgili Gianni²,Gordon Iris³,Bunce Catey⁴,Chakravarthy Usha⁵,Desai Parul⁶,Fletcher Astrid⁷

Affiliation:

1. London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision, ICEH; Keppel Street London UK WC1E 7HT

2. University of Florence; Department of Translational Surgery and Medicine, Eye Clinic; Largo Brambilla, 3 Florence Italy 50134

3. London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision Group, ICEH; Keppel Street London UK WC1E 7HT

4. Kings College London; Department of Primary Care & Public Health Sciences; 4th Floor, Addison House Guy's Campus London UK SE1 1UL

5. Queen's University Belfast; Centre for Vision and Vascular Science; Belfast Northern Ireland UK BT12 6BA

6. Moorfields Eye Hospital NHS Foundation Trust; City Road London UK EC1V 2PD

7. London School of Hygiene & Tropical Medicine; Epidemiology Unit; Keppel Street London UK WC1E 7HT

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007650.pub2/epdf/full

Reference17 articles.

1. Avastin for age-related macular degeneration;Adlbrecht;Ludwig Boltzman Institute: Wien,2007

2. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE;Boluyt;Archives of Pediatrics & Adolescent Medicine,2008

3. Pegaptanib: a novel approach to ocular neovascularization;Chapman Julie;The Annals of pharmacotherapy

4. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation;Colquitt;Health technology assessment (Winchester, England)